Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Robert P. Kadlec"'
Autor:
Anastasia S. Lambrou, John T. Redd, Miles A. Stewart, Kaitlin Rainwater-Lovett, Jonathan K. Thornhill, Lynn Hayes, Gina Smith, George M. Thorp, Christian Tomaszewski, Adolphe Edward, Natalia Elías Calles, Mark Amox, Steven Merta, Tiffany Pfundt, Victoria Callahan, Adam Tewell, Helga Scharf-Bell, Samuel Imbriale, Jeffrey D. Freeman, Michael Anderson, Robert P. Kadlec
Publikováno v:
Disaster medicine and public health preparedness.
Monoclonal antibody therapeutics to treat coronavirus disease (COVID-19) have been authorized by the US Food and Drug Administration under Emergency Use Authorization (EUA). Many barriers exist when deploying a novel therapeutic during an ongoing pan
Autor:
Michael Anderson, Tyler Cluff, Jonathan K Thornhill, Christopher E. Bradburne, Robert P Kadlec, Anastasia S. Lambrou, Mark J. Panaggio, Miles Stewart, John T. Redd, Samuel Imbriale, Jeffrey Freeman, Mike Fang, Natalia Elias Calles, Kaitlin Rainwater-Lovett
Publikováno v:
Open Forum Infectious Diseases
BackgroundMonoclonal antibodies (mAbs) against SARS-CoV-2 are a promising treatment for limiting the progression of COVID-19 and decreasing strain on hospitals. Their use, however, remains limited, particularly in disadvantaged populations.MethodsEle
Autor:
Miles Stewart, Adam Tewell, Jonathan K Thornhill, Tiffany Pfundt, Christian Tomaszewski, Helga Scharf-Bell, George M Thorp, Mark Amox, Jeffrey Freeman, Anastasia S. Lambrou, Victoria Callahan, Lynn Hayes, Michael Anderson, Robert P Kadlec, Natalia Elias Calles, Steven Merta, Kaitlin Rainwater-Lovett, Gina Smith, Adolphe Edward, Samuel Imbriale, John T. Redd
BackgroundThe COVID-19 pandemic caught the globe unprepared without targeted medical countermeasures, such as therapeutics, to target the emerging SARS-CoV-2 virus. However, in recent months multiple monoclonal antibody therapeutics to treat COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f590696c534a477c48f87c5e408f2f22
https://doi.org/10.1101/2021.04.05.21254707
https://doi.org/10.1101/2021.04.05.21254707
Autor:
Robert H. Kadlec
Publikováno v:
Water, Vol 8, Iss 6, p 243 (2016)
This paper reviews aspects of the performance of large (>40 ha) constructed treatment wetlands intended for phosphorus control. Thirty-seven such wetlands have been built and have good data records, with a median size of 754 ha. All are successfully
Externí odkaz:
https://doaj.org/article/ef935f1c847049e288567c73dd65f811
Autor:
Robert F, DeFraites, Jose L, Sanchez, Cynthia A, Brandt, Robert P, Kadlec, Richard L, Haberberger, Jenny J, Lin, David N, Taylor
Publikováno v:
MSMR. 21(11)
An outbreak of acute gastroenteritis involving 249 persons, 32% of whom were hospitalized, occurred on a U.S. Army installation in 1990. Campylobacter jejuni was isolated from 81 of 163 (50%) persons cultured. Seventeen isolates of C. jejuni availabl
Publikováno v:
JAMA. 278:351
The Biological and Toxin Weapons Convention (BWC), which prohibits the acquisition of biological materials for hostile purposes and armed conflict, entered into force in 1975 and now has the participation of 140 nations (158 nations have signed the B